alpha-D-Glcp-(1->6)-beta-D-Glcp-(1->6)-D-Glcp

Term ID

CHEBI:148308

Synonyms

(3R,4S,5S,6R)-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol
alpha-D-gluco-hexopyranosyl-(1->6)-beta-D-gluco-hexopyranosyl-(1->6)-D-gluco-hexopyranose
alpha-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->6)-D-glucopyranose
Glc(a1-6)Glc(b1-6)Glc
WURCS=2.0/3,3,2/[a2122h-1x_1-5][a2122h-1b_1-5][a2122h-1a_1-5]/1-2-3/a6-b1_b6-c1

(all 5)

Definition

A glucotriose consisting of alpha-D-glucopyranose, beta-D-glucopyranose and D-glucopyranose residues joined in sequence by (1->6) glycosidic bonds.

References

(all 4)

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-D-Glcp-(1->6)-beta-D-Glcp-(1->6)-D-Glcp

Phenotype where environments contain alpha-D-Glcp-(1->6)-beta-D-Glcp-(1->6)-D-Glcp

Phenotype modified by environments containing alpha-D-Glcp-(1->6)-beta-D-Glcp-(1->6)-D-Glcp

Phenotype affecting alpha-D-Glcp-(1->6)-beta-D-Glcp-(1->6)-D-Glcp

Human Disease Model